Piqur

Developer of anti-cancer drugs based on lipid kinase (PI3K) and mTOR inhibition

placeBasel, Basel Stadt, Switzerland calendar_todayFounded 2011 groups9 employees language piqur.com

Innovation

1 patent family (1 granted); filing pace active.

YearFilings
20241

Investor mix

3 investors on record; lead investors include Versant Ventures.

Investor typeCountShare
Venture capital133%
Accelerator & incubator133%
Other / undisclosed133%
Coming soon